biomodal at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
biomodal brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 2116. Its session covers integrated genetic, epigenetic and fragmentomic profiling to support circulating tumor DNA detection and liquid biopsy biomarker discovery. The company sells sequencing chemistry that resolves variants and DNA methylation, including 5mC and 5hmC, from a single low-input sample.
| Organization | AMP 2026 Attendance |
|---|---|
biomodal Saffron Walden, UK | |
Multiomic sequencing chemistry resolving genetic variants and DNA methylation, including 5mC and 5hmC, from a single low-input DNA, cfDNA or FFPE sample. | Booth Exhibiting at Booth 2116 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Thu, Nov 12 4:25pm–4:55pm Integrated genetic, epigenetic and fragmentomic profiling with duet supports ctDNA detection and liquid biopsy biomarker discovery One workflow reads sequence variants, methylation and fragment patterns from the same cell-free DNA, lowering the detection limit for ctDNA. |
Instantly find 20 buyers from biomodal
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction